Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females[S]

Hypercholesterolemia is characterized by high plasma LDL cholesterol and often caused by genetic mutations in LDL receptor (LDLR), APOB, or proprotein convertase subtilisin/kexin type 9 (PCSK9). However, a substantial proportion of hypercholesterolemic subjects do not have any mutations in these canonical genes, leaving the underlying pathobiology to be determined. In this study, we investigated to determine whether combining plasma metabolomics with genetic information increases insight in the biology of hypercholesterolemia. For this proof of concept study, we combined plasma metabolites from 119 hypercholesterolemic females with genetic information on the LDL canonical genes. Using hierarchical clustering, we identified four subtypes of hypercholesterolemia, which could be distinguished along two axes represented by triglyceride and large LDL particle concentration. Subjects with mutations in LDLR or APOB preferentially clustered together, suggesting that patients with defects in the LDLR pathway show a distinctive metabolomics profile. In conclusion, we show the potential of using metabolomics to segregate hypercholesterolemic subjects into different clusters, which may help in targeting genetic analysis.

[1]  J. Danesh,et al.  Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment , 2018, Circulation.

[2]  J. Danesh,et al.  Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition , 2018, bioRxiv.

[3]  R. Sinke,et al.  Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women , 2018, Circulation.

[4]  R. Collins,et al.  Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke , 2018, Journal of the American College of Cardiology.

[5]  A. Pereira,et al.  Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia , 2018, Arquivos brasileiros de cardiologia.

[6]  R. Krauss,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease , 2018 .

[7]  S. Irani,et al.  microRNA-30c reduces plasma cholesterol in homozygous familial hypercholesterolemic and type 2 diabetic mouse models , 2017, Journal of Lipid Research.

[8]  Vhw Dissanayake,et al.  Genetic determinants of inherited susceptibility to hypercholesterolemia – a comprehensive literature review , 2017, Lipids in Health and Disease.

[9]  Lale Tokgözoğlu,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.

[10]  John F. Robinson,et al.  Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[11]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[12]  A. Hofman,et al.  Blood lipids influence DNA methylation in circulating cells , 2016, Genome Biology.

[13]  J. Danesh,et al.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. , 2016, Journal of the American College of Cardiology.

[14]  M. Swertz,et al.  CoNVaDING: Single Exon Variation Detection in Targeted NGS Data , 2016, Human mutation.

[15]  Alun D. Hughes,et al.  Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase , 2016, Journal of the American College of Cardiology.

[16]  Barbara Plecko,et al.  CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL , 2016, Nature Communications.

[17]  J. Goldstein,et al.  A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.

[18]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[19]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[20]  S. Humphries,et al.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations , 2014, Journal of Medical Genetics.

[21]  Pieter B. T. Neerincx,et al.  Supplementary Information Whole-genome sequence variation , population structure and demographic history of the Dutch population , 2022 .

[22]  Zhi-ping Chen,et al.  A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis , 2014, Journal of Lipid Research.

[23]  Toomas Haller,et al.  Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons , 2014, PLoS medicine.

[24]  Sonia Shah,et al.  Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study , 2013, The Lancet.

[25]  J. Bonnet,et al.  Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease[S] , 2012, Journal of Lipid Research.

[26]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[27]  J. Weissenbach,et al.  A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1 , 2010, European Journal of Human Genetics.

[28]  S. G. Hadfield,et al.  Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project , 2010, Clinical genetics.

[29]  Tom R. Gaunt,et al.  Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. , 2009, American journal of human genetics.

[30]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[31]  A. Soutar,et al.  Mechanisms of Disease: genetic causes of familial hypercholesterolemia , 2007, Nature Clinical Practice Cardiovascular Medicine.

[32]  A. Tall,et al.  Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice* , 2002, The Journal of Biological Chemistry.

[33]  C. Packard,et al.  Lipoprotein heterogeneity and apolipoprotein B metabolism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.